Literature DB >> 25336558

Severe Langerhans cell histiocytosis in an infant: haemophagocytic syndrome association.

Marta Isabel Póvoas1, Pedro Pereira Luís2, Isabel Esteves3, Anabela Ferrão3.   

Abstract

Langerhans cell histiocytosis (LCH) is a rare disease of unknown origin with a heterogeneous clinical presentation, varying from benign and self-limited to lethal. It is classified as single or multisystemic, according to the number of organs involved (one or at least two, respectively). Diagnosis can be challenging and is based on the histological and immunophenotypic examination of affected tissues. Secondary haemophagocytic lymphohistiocytosis is rarely reported in association with LCH and may impair its diagnosis. Some authors suggest that the coexistence of the two disorders is more than coincidental. We present a case of multisystem LCH in a 5-month-old infant, with all risk organs involved, in which severity and rapid progression reflect an association with haemophagocytic syndrome. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25336558      PMCID: PMC4208108          DOI: 10.1136/bcr-2014-206983

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  13 in total

1.  Macrophage activation and hemophagocytic syndrome in langerhans cell histiocytosis: report of 30 cases.

Authors:  Blaise E Favara; Ronald Jaffe; R Maarten Egeler
Journal:  Pediatr Dev Pathol       Date:  2002 Mar-Apr

Review 2.  Langerhans cell histiocytosis with digestive tract involvement.

Authors:  Satya P Yadav; Gaurav Kharya; Neelam Mohan; Anupam Sehgal; Sunil Bhat; Sandeep Jain; Gauri Kapoor; Anupam Sachdeva
Journal:  Pediatr Blood Cancer       Date:  2010-10       Impact factor: 3.167

3.  Recurrent viral associated hemophagocytic syndrome in a child with Langerhans cell histiocytosis.

Authors:  A Klein; F Corazza; A Demulder; D Van Beers; A Ferster
Journal:  J Pediatr Hematol Oncol       Date:  1999 Nov-Dec       Impact factor: 1.289

4.  HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.

Authors:  Jan-Inge Henter; Annacarin Horne; Maurizio Aricó; R Maarten Egeler; Alexandra H Filipovich; Shinsaku Imashuku; Stephan Ladisch; Ken McClain; David Webb; Jacek Winiarski; Gritta Janka
Journal:  Pediatr Blood Cancer       Date:  2007-02       Impact factor: 3.167

5.  [Langerhans cell histiocytosis: Letterer-Siwe disease - the importance of dermatological diagnosis in two cases].

Authors:  Leonardo Mello Ferreira; Paulo Sergio Emerich; Lucia Martins Diniz; Luciene Lage; Isabella Redighieri
Journal:  An Bras Dermatol       Date:  2009 Jul-Aug       Impact factor: 1.896

Review 6.  Protein-losing enteropathy caused by gastrointestinal tract-involved Langerhans cell histiocytosis.

Authors:  Haruko Shima; Takao Takahashi; Hiroyuki Shimada
Journal:  Pediatrics       Date:  2010-01-18       Impact factor: 7.124

Review 7.  Histiocytic disorders: recent insights into pathophysiology and practical guidelines.

Authors:  Alexandra Filipovich; Kenneth McClain; Alexei Grom
Journal:  Biol Blood Marrow Transplant       Date:  2009-11-22       Impact factor: 5.742

8.  Letterer siwe disease.

Authors:  A E George; K Yogirajan
Journal:  Indian J Dermatol Venereol Leprol       Date:  2001 Nov-Dec       Impact factor: 2.545

9.  Simultaneous occurrence of viral-associated hemophagocytic syndrome and Langerhans cell histiocytosis: a case report.

Authors:  P B Hesseling; G Wessels; R M Egeler; D J Rossouw
Journal:  Pediatr Hematol Oncol       Date:  1995 Mar-Apr       Impact factor: 1.969

10.  Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years.

Authors:  Riccardo Haupt; Milen Minkov; Itziar Astigarraga; Eva Schäfer; Vasanta Nanduri; Rima Jubran; R Maarten Egeler; Gritta Janka; Dragan Micic; Carlos Rodriguez-Galindo; Stefaan Van Gool; Johannes Visser; Sheila Weitzman; Jean Donadieu
Journal:  Pediatr Blood Cancer       Date:  2012-10-25       Impact factor: 3.167

View more
  3 in total

1.  A multicenter study of patients with multisystem Langerhans cell histiocytosis who develop secondary hemophagocytic lymphohistiocytosis.

Authors:  Deepak Chellapandian; Melissa R Hines; Rui Zhang; Michael Jeng; Cor van den Bos; Vicente Santa-María López; Kai Lehmberg; Elena Sieni; Yini Wang; Taizo Nakano; James A Williams; Nicholas J Fustino; Itziar Astigarraga; Ira J Dunkel; Oussama Abla; Astrid G S van Halteren; Deqing Pei; Cheng Cheng; Sheila Weitzman; Lillian Sung; Kim E Nichols
Journal:  Cancer       Date:  2018-12-06       Impact factor: 6.860

2.  Multisystem Langerhans Cell Histiocytosis in Younger Infants First Presenting in Skin: A Case Series.

Authors:  Dan Han; Fei Li; Wahid H Yahya; Rui Ge; Yan Zhao; Bei Liu; Yan Zhou; Zhuoyu Wen
Journal:  J Pers Med       Date:  2022-06-22

3.  High-risk LCH in infants is serially transplantable in a xenograft model but responds durably to targeted therapy.

Authors:  Lynn H Lee; Christa Krupski; Jason Clark; Mark Wunderlich; Robert B Lorsbach; Michael S Grimley; Matthew Burwinkel; Adam Nelson; Ashish R Kumar
Journal:  Blood Adv       Date:  2020-02-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.